These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 25879005)

  • 21. Long-term treatment patterns of testosterone replacement medications.
    Donatucci C; Cui Z; Fang Y; Muram D
    J Sex Med; 2014 Aug; 11(8):2092-9. PubMed ID: 24909541
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Risks of testosterone replacement therapy in ageing men.
    Tan RS; Salazar JA
    Expert Opin Drug Saf; 2004 Nov; 3(6):599-606. PubMed ID: 15500418
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Testosterone therapy of men with type 2 diabetes mellitus - a randomized, double-blinded, placebo-controlled study.
    Magnussen LV
    Dan Med J; 2017 Jul; 64(7):. PubMed ID: 28673384
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Testosterone replacement therapy in hypogonadal men: assessing benefits, risks, and best practices.
    Miner M; Canty DJ; Shabsigh R
    Postgrad Med; 2008 Sep; 120(3):130-53. PubMed ID: 18824832
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Late-life onset hypogonadism: a review.
    Bassil N; Morley JE
    Clin Geriatr Med; 2010 May; 26(2):197-222. PubMed ID: 20497841
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Testosterone and prostate cancer: an evidence-based review of pathogenesis and oncologic risk.
    Michaud JE; Billups KL; Partin AW
    Ther Adv Urol; 2015 Dec; 7(6):378-87. PubMed ID: 26622322
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cardiovascular risks and elevation of serum DHT vary by route of testosterone administration: a systematic review and meta-analysis.
    Borst SE; Shuster JJ; Zou B; Ye F; Jia H; Wokhlu A; Yarrow JF
    BMC Med; 2014 Nov; 12():211. PubMed ID: 25428524
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Testosterone replacement therapy can increase circulating endothelial progenitor cell number in men with late onset hypogonadism.
    Liao CH; Wu YN; Lin FY; Tsai WK; Liu SP; Chiang HS
    Andrology; 2013 Jul; 1(4):563-9. PubMed ID: 23653307
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The benefits and risks of testosterone replacement therapy: a review.
    Bassil N; Alkaade S; Morley JE
    Ther Clin Risk Manag; 2009 Jun; 5(3):427-48. PubMed ID: 19707253
    [TBL] [Abstract][Full Text] [Related]  

  • 30. State-of-the-Art: a Review of Cardiovascular Effects of Testosterone Replacement Therapy in Adult Males.
    Elsherbiny A; Tricomi M; Bhatt D; Dandapantula HK
    Curr Cardiol Rep; 2017 Apr; 19(4):35. PubMed ID: 28361372
    [TBL] [Abstract][Full Text] [Related]  

  • 31. EMAS position statement: Testosterone replacement therapy in the aging male‏.
    Dimopoulou C; Ceausu I; Depypere H; Lambrinoudaki I; Mueck A; Pérez-López FR; Rees M; van der Schouw YT; Senturk LM; Simonsini T; Stevenson JC; Stute P; Goulis DG
    Maturitas; 2016 Feb; 84():94-9. PubMed ID: 26614257
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hypogonadism and Testosterone Therapy: Associations With Cardiovascular Risk.
    Maganty A; Osterberg EC; Ramasamy R
    Am J Mens Health; 2015 Jul; 9(4):340-4. PubMed ID: 24972716
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Testosterone replacement for hypogonadism after treatment of early prostate cancer with brachytherapy.
    Sarosdy MF
    Cancer; 2007 Feb; 109(3):536-41. PubMed ID: 17183557
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association Between Testosterone Replacement Therapy and the Incidence of DVT and Pulmonary Embolism: A Retrospective Cohort Study of the Veterans Administration Database.
    Sharma R; Oni OA; Chen G; Sharma M; Dawn B; Sharma R; Parashara D; Savin VJ; Barua RS; Gupta K
    Chest; 2016 Sep; 150(3):563-71. PubMed ID: 27179907
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cardiovascular and Cerebrovascular Safety of Testosterone Replacement Therapy Among Aging Men with Low Testosterone Levels: A Cohort Study.
    Loo SY; Azoulay L; Nie R; Dell'Aniello S; Yu OHY; Renoux C
    Am J Med; 2019 Sep; 132(9):1069-1077.e4. PubMed ID: 30953635
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Recurrence of prostate cancer in patients receiving testosterone supplementation for hypogonadism.
    Gray H; Seltzer J; Talbert RL
    Am J Health Syst Pharm; 2015 Apr; 72(7):536-41. PubMed ID: 25788507
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of intermission and resumption of long-term testosterone replacement therapy on body weight and metabolic parameters in hypogonadal in middle-aged and elderly men.
    Yassin A; Almehmadi Y; Saad F; Doros G; Gooren L
    Clin Endocrinol (Oxf); 2016 Jan; 84(1):107-14. PubMed ID: 26331709
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Testosterone replacement therapy is associated with an increased risk of urolithiasis.
    McClintock TR; Valovska MI; Kwon NK; Cole AP; Jiang W; Kathrins MN; Bhojani N; Haleblian GE; Koehlmoos T; Haider AH; Basaria S; Trinh QD
    World J Urol; 2019 Dec; 37(12):2737-2746. PubMed ID: 30903351
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Update on Testosterone Replacement Therapy in Hypogonadal Men.
    Leung KM; Alrabeeah K; Carrier S
    Curr Urol Rep; 2015 Aug; 16(8):57. PubMed ID: 26077352
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Testosterone replacement therapy in men with prostate cancer: a time-varying analysis.
    Kaplan AL; Lenis AT; Shah A; Rajfer J; Hu JC
    J Sex Med; 2015 Feb; 12(2):374-80. PubMed ID: 25496237
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.